In this summary Rosen and Myerburg “analyze the basic science and translational strategies supporting the rapid advance of stem cell technology to the clinic.”
Past Statistics
There have been many advance in cardiovascular medicine throughout the past 5 decades
During the past two decades, phase 2 and proof-of-concept have been used on thousands of patients
These processes are mostly being used on patients that have tried other strategies and the other processes have failed regenerative therapy
Target repair or replacement of lost or dysfunctional substrates
Has been recently used in clinical application on large quantities of people
Morbidity and Mortality
The number of Acute Myocardial Infarction (AMI) (heart attack) have been decreasing